STOCK TITAN
  1. Home
  2. Sec-filings
  3. LLY
  4. [Form 4] ELI LILLY & Co Insider Trading Activity

Eli Lilly (NYSE: LLY) director defers pay into new stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ELI LILLY & Co (LLY) director Juan R. Luciano reported the acquisition of 13.4527 shares of common stock on 2026-08-17 through a grant/award. According to the deferral election, these shares have been credited as stock units under the Lilly Directors' Deferral Plan in lieu of cash compensation and will be settled in common stock after his separation from service. Following this award, his directly owned position is reported as 16,918.0448 shares.

Positive

  • None.

Negative

  • None.
Insider LUCIANO JUAN R
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 13.4527 $1,183.16 $16K
Holdings After Transaction: Common Stock — 16,918.0448 shares (Direct)
Footnotes (1)
  1. F1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Shares acquired 13.4527 shares Grant/award of common stock to Juan R. Luciano on 2026-08-17
Grant price per share $1,183.16 per share Price applied to the 13.4527-share grant/award
Total shares after transaction 16,918.0448 shares Directly owned Eli Lilly common stock following the reported acquisition
Lilly Directors' Deferral Plan financial
"as stock units under the Lilly Directors' Deferral Plan and will be settled"
stock units financial
"shares acquired ... have been deferred in lieu of cash compensation as stock units"
Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.
deferred in lieu of cash compensation financial
"have been deferred in lieu of cash compensation as stock units under"

FAQ

What transaction did LLY director Juan R. Luciano report on this Form 4?
Juan R. Luciano reported an acquisition of 13.4527 shares of Eli Lilly common stock on 2026-08-17 via a grant/award, increasing his directly owned holdings to 16,918.0448 shares after the transaction.

How many LLY shares does Juan R. Luciano own after this reported transaction?
After the reported grant, Juan R. Luciano holds 16,918.0448 shares of Eli Lilly common stock directly. This figure reflects his updated ownership position following the acquisition of 13.4527 shares reported on 2026-08-17.

What was the price used for the LLY stock grant to Juan R. Luciano?
The stock grant to Juan R. Luciano used a price of $1,183.16 per share. This price applies to the 13.4527 shares acquired through the grant/award transaction reported on 2026-08-17.

How was the LLY director’s compensation structured in this Form 4 transaction?
Juan R. Luciano elected to receive compensation in stock units instead of cash under the Lilly Directors' Deferral Plan. The 13.4527 acquired shares are deferred as stock units and will be settled in common stock after his separation from service.

Does this LLY Form 4 involve a sale of shares by Juan R. Luciano?
No. The Form 4 reports only an acquisition of 13.4527 shares through a grant/award. There are no sale transactions or dispositions reported, and his total direct holdings rise to 16,918.0448 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LUCIANO JUAN R
(Last)(First)(Middle)
LILLY CORPORATE CENTER
(Street)
INDIANAPOLIS INDIANA 46285
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/17/2026A13.4527(1)A$1,183.1616,918.0448D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Remarks:
/s/ Jonathan Groff for Juan R. Luciano, pursuant to authorization on file08/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR